Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021859

EVP of Sales & Marketing bought 28,844 shares at $0.52 ($14,999)

From the SEC's structured data for this filing

Trades in this filing

Krachon Michael · EVP of Sales & Marketing

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-22 Purchase : show line 1 in the form +28,844 $0.52 $14,999 83,844 D
Open-market purchases · 28,844 sh · avg $0.52 · $14,999

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-22 Purchase : show line 2 in the form Warrant (right to buy) +14,422 689,422 D
Loading xslF345X03/rdgdoc.xml…